Levonordefrin
-
Levonordefrin
structure -
-
CAS No:
829-74-3
-
Formula:
C9H13NO3
-
Chemical Name:
Levonordefrin
-
Synonyms:
1,2-Benzenediol,4-[(1R,2S)-2-amino-1-hydroxypropyl]-;Benzyl alcohol,α-(1-aminoethyl)-3,4-dihydroxy-,erythro-(-)-;1,2-Benzenediol,4-(2-amino-1-hydroxypropyl)-,[R-(R*,S*)]-;l-Norephedrine,3,4-dihydroxy-;4-[(1R,2S)-2-Amino-1-hydroxypropyl]-1,2-benzenediol;l-α-(1-Aminoethyl)-3,4-dihydroxybenzyl alcohol;Levonordefrin;(-)-α-Methylnoradrenaline;(-)-Nordefrin;(-)-erythro-α-Methylnoradrenaline;BA 2818;D-(-)-Cobefrin;L-α-Methylnoradrenaline;(-)-Cobefrin;Corbadrine;l-Cobefrin;(1R,2S)-(-)-3,4-Dihydroxynorephedrine;4-((1R,2S)-2-Amino-1-hydroxypropyl)benzene-1,2-diol;Neo-cobefrin;13725-11-6;16906-83-5;18829-78-2;34535-70-1
- Categories:
-
CAS No:
Description
White Powder
Solid
Alpha-methylnoradrenaline is a catecholamine in which the 2-aminoethyl group is substituted with a hydroxy group at C-1 and a methyl group at C-2, with configurations 1R,2S. A metabolite of alpha-methyl-L-dopa, it is an alpha2-adrenergic agonist and acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry. It has a role as an alpha-adrenergic agonist, a vasoconstrictor agent and a nasal decongestant.|Levonordefrin acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry.|Levonordefrin is the levoisomer of nordefrin, a synthetic catecholamine and norepinephrine derivative with sympathomimetic and antihypertensive effects. Levonordefrin's antihypertensive effect is exerted through activation of alpha 2-adrenergic receptors in the cardiovascular control center of the CNS thereby suppressing the sympathetic output from the brain and subsequently lowering blood pressure. Levonordefrin binds to and activates peripheral alpha 2- adrenergic receptors, thereby causing vasoconstriction.|A norepinephrine derivative used as a vasoconstrictor agent.
Characteristics
86.7
1.17870
white to light brown
1.328g/cm3
212-215°C dec.
431.575ºC at 760 mmHg
214.809ºC
1.633
DMSO: soluble 5mg/mL, clear (warmed)
−20°C
LD50 in mice (mg/kg): 12.6 i.v. (Luduena)
D25 -31.0° (c = 0.5 in 0.01N HCl)
Safety Information
UN 2811 6.1 / PGII
3
20/21/22-36/37/38
26-36
Xn
P261-P280-P301 + P312 + P330-P305 + P351 + P338
H302 + H312 + H332-H315-H319-H335
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Used as a topical nasal decongestant and vasoconstrictor in dentistry.
Levonordefrin is a sympathomimetic amine used as a vasoconstrictor in local anesthetic solutions. It has pharmacologic activity similar to that of Epinephrine but it is more stable than Epinephrine. In equal concentrations, Levonordefrin is less potent than Epinephrine in raising blood pressure, and as a vasoconstrictor.
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
It is designed to mimic the molecular shape of adrenaline. It binds to alpha-adrenergic receptors in the nasal mucosa. Here it can, therefore, cause vasoconstriction.
3,4 Dihydroxynorephedrine
Levonordefrin Use and Manufacturing
Vasoconstrictor;Adrenergic receptor agonist
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:183.20
XLogP3:-0.8
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:2
Exact Mass:183.08954328
Monoisotopic Mass:183.08954328
Topological Polar Surface Area:86.7
Heavy Atom Count:13
Complexity:165
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
4,4′-(1,2-Diazenediyl)bis[N,N,N-trimethylbenzenaminium]
21704-61-0
-
N-(4-Chloro-2-methylphenyl)formamide
21787-81-5
-
Basic Blue 8
2185-87-7
-
3-tert-butyl-5-chloro-2-hydroxy-N-(2-nitrosophenyl)benzamide Formula
21889-00-9
-
1-Phenylcyclohexylamine Formula
2201-24-3
-
6-Hydroxymelatonin Formula
2208-41-5
-
Pyrrocaine Structure
2210-77-7
-
2-amino-N-(4-ethoxyphenyl)ethanesulfonamide Structure
22103-30-6
-
What is Bufeniode
22103-14-6
-
What is 4-(2-Quinolinyl)benzenamine
22191-97-5